ProAssurance Corporation

Valuation Analysis

About the Company

ProAssurance Corporation, through its subsidiaries, provides property and casualty insurance, and reinsurance products in the United States. It operates through three segments: Specialty Property and Casualty, Workers' Compensation Insurance, Segregated Portfolio Cell Reinsurance, and Corporate. The company offers professional liability insurance to healthcare providers and institutions, and attorneys and their firms; medical technology liability insurance to medical technology and life sciences companies; and custom alternative risk solutions, including assumed reinsurance and captive cell programs for healthcare professional liability insureds. It also provides workers' compensation insurance products, such as guaranteed cost policies, policyholder dividend policies, retrospectively rate

ProAssurance Corporation Stock at a Glance

ProAssurance Corporation (PRA) is currently trading at $24.72 with a market capitalization of $1.3B. The trailing P/E ratio stands at 19.62x, with a forward P/E of 19.78x. The 52-week range spans from $22.72 to $24.85; the current price is 0.5% below the yearly high. Year-over-year revenue growth stands at -4.9%. The net profit margin stands at 5.95%.

💰 Dividend

ProAssurance Corporation currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.

📊 Analyst Rating

2 analysts rate ProAssurance Corporation (PRA) on consensus: None. The average price target is $25.00, implying +1.13% from the current price. Analyst price targets range from $25.00 to $25.00.

ProAssurance Corporation: The Investment Case in Detail

ProAssurance Corporation (PRA) operates in the Financial Services — specifically Insurance - Property & Casualty — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

The Bear Case

Revenue is contracting at -4.9% year-over-year — until that trend reverses, valuation is exposed to further downgrades. Short interest sits at 24.05% of float — a meaningful contingent of professionals is positioned for the share to fall, which deserves attention even if their thesis may turn out to be wrong.

Valuation in Context

With a PEG ratio of 0.78, the price-to-earnings multiple is actually below the company's growth rate — classic value-meets-growth territory that Peter Lynch would have called a 'GARP' opportunity. The EV/EBITDA multiple of 9.7x is below the historical equity-market average — strategic acquirers would find the cash-flow profile attractive at this level.

What to Watch Next

• The share is trading at 93.9% of its 52-week range — a break above the recent high opens technical upside, a failure here often invites profit-taking.

Investment Thesis: Strengths & Weaknesses

Technical Snapshot

Price trades above both the 50- and 200-day moving averages, with 50d above 200d — a classic bullish setup (golden-cross alignment).

Risk Profile

The data points to relatively defensive market behavior, elevated short interest (24.05%).

Trading Data

Related Stocks in the Same Sector

Where can I buy ProAssurance Corporation?

Compare top-rated brokers — low fees, trusted providers, fully regulated.